Insurance CEO Says Weight Loss Drug Coverage Led to Layoffs, Financial Losses
A healthcare CEO told NBC News that insurance plans covering weight loss drugs caused major financial losses and forced the company to lay off workers. Most insurance plans currently don't cover these expensive medications.
A healthcare executive revealed that covering weight loss medications led to significant financial strain on insurance plans, resulting in layoffs at the company. The CEO spoke with NBC News as part of their series examining insurance coverage denials.
Weight loss drugs have become increasingly popular but carry high price tags. Many insurance plans already refuse to cover these medications, leaving patients to pay hundreds of dollars monthly out of their own pockets.
The coverage gap is especially pronounced for Medicare patients. Federal law prohibits Medicare from covering weight loss medications entirely, forcing seniors to pay full retail prices.
Insurance companies face a difficult balance between providing access to new treatments and managing costs that could drive up premiums for all members. The high cost of weight loss drugs appears to be tipping that balance toward more restrictive coverage policies.
Weight loss drugs like Ozempic can cost hundreds of dollars per month out of pocket. If more insurers stop covering them due to costs, patients may lose access to potentially life-changing treatments for obesity.
More insurers may reduce or eliminate coverage for weight loss drugs as costs mount.
Was this article helpful?
0 people found this helpful